AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 876.34% | -80.17% | -27.06% | 5,945.45% | -101.41% |
| Total Depreciation and Amortization | -3.68% | 0.63% | 0.54% | -3.00% | 1.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.39% | 29.15% | 206.40% | -83.41% | 407.57% |
| Change in Net Operating Assets | -137.75% | 322.95% | 78.22% | -549.87% | -152.93% |
| Cash from Operations | -25.71% | 36.31% | 215.17% | -76.80% | 29.39% |
| Capital Expenditure | 13.65% | -41.64% | -14.47% | 19.24% | -16.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 58.57% | -198.09% | -74.72% | 69.98% | 78.90% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.33% | -389.29% | -26.32% | -81.82% | -57.00% |
| Cash from Investing | 55.18% | -176.38% | -60.68% | 60.78% | 77.30% |
| Total Debt Issued | -307.47% | -93.92% | -29.07% | 179.35% | -- |
| Total Debt Repaid | 60.37% | 46.30% | -24.06% | 47.48% | -1,329.78% |
| Issuance of Common Stock | -23.81% | 1,160.00% | -91.07% | 460.00% | -85.07% |
| Repurchase of Common Stock | 25.00% | 66.67% | 98.75% | -168.44% | -2,005.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -0.03% | 0.51% | -6.29% | -0.04% |
| Other Financing Activities | -102.70% | 1,950.00% | -118.18% | 1,000.00% | -96.88% |
| Cash from Financing | 9.24% | -69.37% | -115.42% | 81.66% | -123.34% |
| Foreign Exchange rate Adjustments | 237.50% | -126.67% | 233.33% | 119.57% | -675.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.27% | -164.86% | 470.20% | 79.86% | 70.49% |